{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:17:04Z","timestamp":1780589824540,"version":"3.54.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"RFUMS-H.M. Bligh Cancer Research Fund","award":["6100-2289-1111103"],"award-info":[{"award-number":["6100-2289-1111103"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12985-017-0891-5","type":"journal-article","created":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T12:35:36Z","timestamp":1510576536000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Interferon-\u03b3-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6607-6997","authenticated-orcid":false,"given":"Gina","family":"Pisano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunava","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mairaj","family":"Ahmed Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binod","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leela","family":"Chikoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bala","family":"Chandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,13]]},"reference":[{"key":"891_CR1","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1126\/science.157.3792.1064","volume":"157","author":"W Henle","year":"1967","unstructured":"Henle W, Diehl V, Kohn G, Zur Hausen H, Henle G. Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells. Science. 1967;157:1064\u20135.","journal-title":"Science"},{"key":"891_CR2","doi-asserted-by":"crossref","first-page":"6693","DOI":"10.1128\/JVI.00219-13","volume":"87","author":"A Sugimoto","year":"2013","unstructured":"Sugimoto A, Sato Y, Kanda T, Murata T, Narita Y, Kawashima D, Kimura H, Tsurumi T. Different distributions of Epstein-Barr virus early and late gene transcripts within viral replication compartments. J Virol. 2013;87:6693\u20139.","journal-title":"J Virol"},{"key":"891_CR3","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1128\/JVI.66.1.122-131.1992","volume":"66","author":"M Rowe","year":"1992","unstructured":"Rowe M, Lear AL, Croom-Carter D, Davies AH, Rickinson AB. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes. J Virol. 1992;66:122\u201331.","journal-title":"J Virol"},{"key":"891_CR4","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1056\/NEJM198405103101905","volume":"310","author":"JW Sixbey","year":"1984","unstructured":"Sixbey JW, Nedrud JG, Raab-Traub N, Hanes RA, Pagano JS. Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med. 1984;310:1225\u201330.","journal-title":"N Engl J Med"},{"key":"891_CR5","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1182\/blood.V85.3.744.bloodjournal853744","volume":"85","author":"I Anagnostopoulos","year":"1995","unstructured":"Anagnostopoulos I, Hummel M, Kreschel C, Stein H. Morphology, immunophenotype, and distribution of latently and\/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. Blood. 1995;85:744\u201350.","journal-title":"Blood"},{"key":"891_CR6","volume-title":"EBV gene expression and regulation. In Human Herpesviruses: biology, therapy, and Immunoprophylaxis","author":"YLS AJ","year":"2007","unstructured":"AJ YLS, Murray PG. EBV gene expression and regulation. In Human Herpesviruses: biology, therapy, and Immunoprophylaxis. In: A C-FG A, Mocarski E, et al., editors. . Cambridge: Cambridge University Press; 2007."},{"key":"891_CR7","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.7150\/ijbs.16564","volume":"12","author":"H Li","year":"2016","unstructured":"Li H, Liu S, Hu J, Luo X, Li N, Ann MB, Cao Y. Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis. Int J Biol Sci. 2016;12:1309\u201318.","journal-title":"Int J Biol Sci"},{"key":"891_CR8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1098\/rstb.2000.0781","volume":"356","author":"GW Bornkamm","year":"2001","unstructured":"Bornkamm GW, Hammerschmidt W. Molecular virology of Epstein-Barr virus. Philos Trans R Soc Lond Ser B Biol Sci. 2001;356:437\u201359.","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"key":"891_CR9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12985-016-0602-7","volume":"13","author":"C Harold","year":"2016","unstructured":"Harold C, Cox D, Riley KJ. Epstein-Barr viral microRNAs target caspase 3. Virol J. 2016;13:145.","journal-title":"Virol J"},{"key":"891_CR10","doi-asserted-by":"crossref","first-page":"9115","DOI":"10.1128\/JVI.74.19.9115-9124.2000","volume":"74","author":"M Merchant","year":"2000","unstructured":"Merchant M, Caldwell RG, Longnecker R. The LMP2A ITAM is essential for providing B cells with development and survival signals in vivo. J Virol. 2000;74:9115\u201324.","journal-title":"J Virol"},{"key":"891_CR11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1084\/jem.176.1.157","volume":"176","author":"RJ Murray","year":"1992","unstructured":"Murray RJ, Kurilla MG, Brooks JM, Thomas WA, Rowe M, Kieff E, Rickinson AB. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J Exp Med. 1992;176:157\u201368.","journal-title":"J Exp Med"},{"key":"891_CR12","doi-asserted-by":"crossref","unstructured":"Khanna R, Burrows SR, Kurilla MG, Jacob CA, Misko IS, Sculley TB, Kieff E, Moss DJ: Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. J Exp Med 1992, 176:169-176.","DOI":"10.1084\/jem.176.1.169"},{"key":"891_CR13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF00218044","volume":"36","author":"JA Trapani","year":"1992","unstructured":"Trapani JA, Browne KA, Dawson MJ, Ramsay RG, Eddy RL, Show TB, White PC, Dupont B. A novel gene constitutively expressed in human lymphoid cells is inducible with interferon-gamma in myeloid cells. Immunogenetics. 1992;36:369\u201376.","journal-title":"Immunogenetics"},{"key":"891_CR14","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.chom.2011.04.008","volume":"9","author":"N Kerur","year":"2011","unstructured":"Kerur N, Veettil MV, Sharma-Walia N, Bottero V, Sadagopan S, Otageri P, Chandran B. IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi sarcoma-associated herpesvirus infection. Cell Host Microbe. 2011;9:363\u201375.","journal-title":"Cell Host Microbe"},{"key":"891_CR15","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1128\/JVI.03282-12","volume":"87","author":"VV Singh","year":"2013","unstructured":"Singh VV, Kerur N, Bottero V, Dutta S, Chakraborty S, Ansari MA, Paudel N, Chikoti L, Chandran B. Kaposi's sarcoma-associated herpesvirus latency in endothelial and B cells activates gamma interferon-inducible protein 16-mediated inflammasomes. J Virol. 2013;87:4417\u201331.","journal-title":"J Virol"},{"key":"891_CR16","doi-asserted-by":"crossref","first-page":"8606","DOI":"10.1128\/JVI.00805-13","volume":"87","author":"MA Ansari","year":"2013","unstructured":"Ansari MA, Singh VV, Dutta S, Veettil MV, Dutta D, Chikoti L, Lu J, Everly D, Chandran B. Constitutive interferon-inducible protein 16-inflammasome activation during Epstein-Barr virus latency I, II, and III in B and epithelial cells. J Virol. 2013;87:8606\u201323.","journal-title":"J Virol"},{"key":"891_CR17","doi-asserted-by":"crossref","first-page":"7506","DOI":"10.1128\/JVI.00013-15","volume":"89","author":"I Lo Cigno","year":"2015","unstructured":"Lo Cigno I, De Andrea M, Borgogna C, Albertini S, Landini MM, Peretti A, Johnson KE, Chandran B, Landolfo S, Gariglio M. The nuclear DNA sensor IFI16 acts as a restriction factor for human Papillomavirus replication through epigenetic modifications of the viral promoters. J Virol. 2015;89:7506\u201320.","journal-title":"J Virol"},{"key":"891_CR18","doi-asserted-by":"crossref","first-page":"e1002498","DOI":"10.1371\/journal.ppat.1002498","volume":"8","author":"GR Gariano","year":"2012","unstructured":"Gariano GR, Dell'Oste V, Bronzini M, Gatti D, Luganini A, De Andrea M, Gribaudo G, Gariglio M, Landolfo S. The intracellular DNA sensor IFI16 gene acts as restriction factor for human cytomegalovirus replication. PLoS Pathog. 2012;8:e1002498.","journal-title":"PLoS Pathog"},{"key":"891_CR19","doi-asserted-by":"crossref","first-page":"e1004503","DOI":"10.1371\/journal.ppat.1004503","volume":"10","author":"KE Johnson","year":"2014","unstructured":"Johnson KE, Bottero V, Flaherty S, Dutta S, Singh VV, Chandran B. IFI16 restricts HSV-1 replication by accumulating on the HSV-1 genome, repressing HSV-1 gene expression, and directly or indirectly modulating histone modifications. PLoS Pathog. 2014;10:e1004503.","journal-title":"PLoS Pathog"},{"key":"891_CR20","doi-asserted-by":"crossref","first-page":"8822","DOI":"10.1128\/JVI.01003-16","volume":"90","author":"A Roy","year":"2016","unstructured":"Roy A, Dutta D, Iqbal J, Pisano G, Gjyshi O, Ansari MA, Kumar B, Chandran B. Nuclear innate immune DNA sensor IFI16 is degraded during Lytic reactivation of Kaposi's sarcoma-associated Herpesvirus (KSHV): role of IFI16 in maintenance of KSHV latency. J Virol. 2016;90:8822\u201341.","journal-title":"J Virol"},{"key":"891_CR21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1128\/JVI.60.2.369-375.1986","volume":"60","author":"N Balachandran","year":"1986","unstructured":"Balachandran N, Pittari J, Hutt-Fletcher LM. Detection by monoclonal antibodies of an early membrane protein induced by Epstein-Barr virus. J Virol. 1986;60:369\u201375.","journal-title":"J Virol"},{"key":"891_CR22","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/jmv.2155","volume":"66","author":"JP Zoeteweij","year":"2002","unstructured":"Zoeteweij JP, Rinderknecht AS, Davis DA, Yarchoan R, Blauvelt A. Minimal reactivation of Kaposi's sarcoma-associated herpesvirus by corticosteroids in latently infected B cell lines. J Med Virol. 2002;66:378\u201383.","journal-title":"J Med Virol"},{"key":"891_CR23","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.4049\/jimmunol.172.3.1561","volume":"172","author":"D Iwakiri","year":"2004","unstructured":"Iwakiri D, Takada K. Phosphatidylinositol 3-kinase is a determinant of responsiveness to B cell antigen receptor-mediated Epstein-Barr virus activation. J Immunol. 2004;172:1561\u20136.","journal-title":"J Immunol"},{"key":"891_CR24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1006\/viro.2001.0965","volume":"286","author":"X Gao","year":"2001","unstructured":"Gao X, Ikuta K, Tajima M, Sairenji T. 12-O-tetradecanoylphorbol-13-acetate induces Epstein-Barr virus reactivation via NF-kappaB and AP-1 as regulated by protein kinase C and mitogen-activated protein kinase. Virology. 2001;286:91\u20139.","journal-title":"Virology"},{"key":"891_CR25","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1189\/jlb.0904507","volume":"77","author":"F Gugliesi","year":"2005","unstructured":"Gugliesi F, Mondini M, Ravera R, Robotti A, de Andrea M, Gribaudo G, Gariglio M, Landolfo S. Up-regulation of the interferon-inducible IFI16 gene by oxidative stress triggers p53 transcriptional activity in endothelial cells. J Leukoc Biol. 2005;77:820\u20139.","journal-title":"J Leukoc Biol"},{"key":"891_CR26","doi-asserted-by":"crossref","first-page":"7073","DOI":"10.1128\/JVI.65.12.7073-7077.1991","volume":"65","author":"EK Flemington","year":"1991","unstructured":"Flemington EK, Goldfeld AE, Speck SH. Efficient transcription of the Epstein-Barr virus immediate-early BZLF1 and BRLF1 genes requires protein synthesis. J Virol. 1991;65:7073\u20137.","journal-title":"J Virol"},{"key":"891_CR27","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1128\/JVI.80.5.2548-2565.2006","volume":"80","author":"J Yuan","year":"2006","unstructured":"Yuan J, Cahir-McFarland E, Zhao B, Kieff E. Virus and cell RNAs expressed during Epstein-Barr virus replication. J Virol. 2006;80:2548\u201365.","journal-title":"J Virol"},{"key":"891_CR28","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1365-2133.2010.10097.x","volume":"164","author":"S Costa","year":"2011","unstructured":"Costa S, Borgogna C, Mondini M, De Andrea M, Meroni PL, Berti E, Gariglio M, Landolfo S. Redistribution of the nuclear protein IFI16 into the cytoplasm of ultraviolet B-exposed keratinocytes as a mechanism of autoantigen processing. Br J Dermatol. 2011;164:282\u201390.","journal-title":"Br J Dermatol"},{"key":"891_CR29","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.cellbi.2004.02.003","volume":"28","author":"MA Hahn","year":"2004","unstructured":"Hahn MA, Mayne GC. Phorbol ester-induced cell death in PC-12 cells overexpressing Bcl-2 is dependent on the time at which cells are treated. Cell Biol Int. 2004;28:345\u201359.","journal-title":"Cell Biol Int"},{"key":"891_CR30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1128\/JVI.18.1.151-155.1976","volume":"18","author":"WC Summers","year":"1976","unstructured":"Summers WC, Klein G. Inhibition of Epstein-Barr virus DNA synthesis and late gene expression by phosphonoacetic acid. J Virol. 1976;18:151\u20135.","journal-title":"J Virol"},{"key":"891_CR31","doi-asserted-by":"crossref","unstructured":"Inman GJ, Binne UK, Parker GA, Farrell PJ, Allday MJ. Activators of the Epstein-Barr Virus Lytic Program Concomitantly Induce Apoptosis, but Lytic Gene Expression Protects from Cell Death. J Virol. 2001;75:2400\u201310.","DOI":"10.1128\/JVI.75.5.2400-2410.2001"},{"key":"891_CR32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/cncr.23522","volume":"113","author":"A Oriol","year":"2008","unstructured":"Oriol A, Ribera JM, Bergua J, Gimenez Mesa E, Grande C, Esteve J, Brunet S, Moreno MJ, Escoda L, Hernandez-Rivas JM, Hoelzer D. High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma: comparison of results in human immunodeficiency virus-infected and noninfected patients. Cancer. 2008;113:117\u201325.","journal-title":"Cancer"},{"key":"891_CR33","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0360-3016(99)00236-9","volume":"45","author":"VF Chong","year":"1999","unstructured":"Chong VF, Rumpel H, Aw YS, Ho GL, Fan YF, Chua EJ. Temporal lobe necrosis following radiation therapy for nasopharyngeal carcinoma: 1H MR spectroscopic findings. Int J Radiat Oncol Biol Phys. 1999;45:699\u2013705.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"891_CR34","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/01.mlg.0000248738.55387.44","volume":"117","author":"PK Ku","year":"2007","unstructured":"Ku PK, Yuen EH, Cheung DM, Chan BY, Ahuja A, Leung SF, Tong MC, van Hasselt A. Early swallowing problems in a cohort of patients with nasopharyngeal carcinoma: Symptomatology and videofluoroscopic findings. Laryngoscope. 2007;117:142\u20136.","journal-title":"Laryngoscope"},{"key":"891_CR35","doi-asserted-by":"crossref","first-page":"17172","DOI":"10.1074\/jbc.273.27.17172","volume":"273","author":"RW Johnstone","year":"1998","unstructured":"Johnstone RW, Kerry JA, Trapani JA. The human interferon-inducible protein, IFI 16, is a repressor of transcription. J Biol Chem. 1998;273:17172\u20137.","journal-title":"J Biol Chem"},{"key":"891_CR36","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1086\/517427","volume":"177","author":"SK Srinivas","year":"1998","unstructured":"Srinivas SK, Sample JT, Sixbey JW. Spontaneous loss of viral episomes accompanying Epstein-Barr virus reactivation in a Burkitt's lymphoma cell line. J Infect Dis. 1998;177:1705\u20139.","journal-title":"J Infect Dis"},{"key":"891_CR37","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/ijc.23685","volume":"123","author":"DP Dittmer","year":"2008","unstructured":"Dittmer DP, Hilscher CJ, Gulley ML, Yang EV, Chen M, Glaser R. Multiple pathways for Epstein-Barr virus episome loss from nasopharyngeal carcinoma. Int J Cancer. 2008;123:2105\u201312.","journal-title":"Int J Cancer"},{"key":"891_CR38","doi-asserted-by":"crossref","first-page":"9150","DOI":"10.1128\/JVI.72.11.9150-9156.1998","volume":"72","author":"J Komano","year":"1998","unstructured":"Komano J, Sugiura M, Takada K. Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata. J Virol. 1998;72:9150\u20136.","journal-title":"J Virol"},{"key":"891_CR39","doi-asserted-by":"crossref","first-page":"E3008","DOI":"10.1073\/pnas.1211302109","volume":"109","author":"MH Orzalli","year":"2012","unstructured":"Orzalli MH, DeLuca NA, Knipe DM. Nuclear IFI16 induction of IRF-3 signaling during herpesviral infection and degradation of IFI16 by the viral ICP0 protein. Proc Natl Acad Sci U S A. 2012;109:E3008\u201317.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"891_CR40","doi-asserted-by":"crossref","first-page":"13422","DOI":"10.1128\/JVI.02474-13","volume":"87","author":"D Cuchet-Lourenco","year":"2013","unstructured":"Cuchet-Lourenco D, Anderson G, Sloan E, Orr A, Everett RD. The viral ubiquitin ligase ICP0 is neither sufficient nor necessary for degradation of the cellular DNA sensor IFI16 during herpes simplex virus 1 infection. J Virol. 2013;87:13422\u201332.","journal-title":"J Virol"},{"key":"891_CR41","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1128\/JVI.00082-13","volume":"87","author":"KE Johnson","year":"2013","unstructured":"Johnson KE, Chikoti L, Chandran B. Herpes simplex virus 1 infection induces activation and subsequent inhibition of the IFI16 and NLRP3 inflammasomes. J Virol. 2013;87:5005\u201318.","journal-title":"J Virol"},{"key":"891_CR42","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1016\/S2214-109X(16)30143-7","volume":"4","author":"M Plummer","year":"2016","unstructured":"Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016;4:e609\u201316.","journal-title":"Lancet Glob Health"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-017-0891-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T18:58:41Z","timestamp":1603306721000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-017-0891-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,13]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["891"],"URL":"https:\/\/doi.org\/10.1186\/s12985-017-0891-5","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,13]]},"article-number":"221"}}